» Articles » PMID: 37306571

and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations

Overview
Specialty Microbiology
Date 2023 Jun 12
PMID 37306571
Authors
Affiliations
Soon will be listed here.
Abstract

and belong to the genus , which comprises 14 other species. is responsible for whooping cough in humans, a severe infection in children and less severe or chronic in adults. These infections are restricted to humans and currently increasing worldwide. is involved in diverse respiratory infections in a wide range of mammals. For instance, the canine infectious respiratory disease complex (CIRDC), characterized by a chronic cough in dogs. At the same time, it is increasingly implicated in human infections, while remaining an important pathogen in the veterinary field. Both can evade and modulate host immune responses to support their persistence, although it is more pronounced in infection. The protective immune responses elicited by both pathogens are comparable, while there are important characteristics in the mechanisms that differ. However, pathogenesis is more difficult to decipher in animal models than those of because of its restriction to humans. Nevertheless, the licensed vaccines for each are different in terms of formulation, route of administration and immune responses induced, with no known cross-reaction between them. Moreover, the target of the mucosal tissues and the induction of long-lasting cellular and humoral responses are required to control and eliminate . In addition, the interaction between both veterinary and human fields are essential for the control of this genus, by preventing the infections in animals and the subsequent zoonotic transmission to humans.

Citing Articles

Monitoring of Pathogens Carried by Imported Flies and Cockroaches at Shenzhen Ports.

Zhang S, Zhao C, Liu G, Guo L, Zhang R, Yan J Trop Med Infect Dis. 2025; 10(2).

PMID: 39998061 PMC: 11860353. DOI: 10.3390/tropicalmed10020057.


The virulence regulator is required for nutrient-induced filamentation in .

Perslow N, Luallen R bioRxiv. 2025; .

PMID: 39868252 PMC: 11761123. DOI: 10.1101/2025.01.19.633786.


MASP1 modulation as a novel therapeutic target in severe pediatric pertussis: insights from a multi-omics approach.

Xu L, Wang C, Liu Y, Zhang Y, Li Z, Pang L Infect Immun. 2025; 93(2):e0027124.

PMID: 39841046 PMC: 11834402. DOI: 10.1128/iai.00271-24.


Case report: First report of and coinfection in an immunocompromised patient.

La Sorda M, Palucci I, Natalini D, Fillo S, Giordani F, Paglione F Front Med (Lausanne). 2024; 11:1470567.

PMID: 39502646 PMC: 11534721. DOI: 10.3389/fmed.2024.1470567.


Mixed Th1/Th2/Th17 Responses Induced by Plant Oil Adjuvant-Based Vaccine in Mice, with Mechanisms Unraveled by RNA-Seq, 16S rRNA and Metabolomics.

Cui X, Xiang Q, Huang Y, Ji Q, Hu Z, Shi T Vaccines (Basel). 2024; 12(10).

PMID: 39460348 PMC: 11512391. DOI: 10.3390/vaccines12101182.


References
1.
Bottero D, Zurita M, Gaillard M, Carriquiriborde F, Martin Aispuro P, Elizagaray M . Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Infection. Front Immunol. 2018; 9:2501. PMC: 6232878. DOI: 10.3389/fimmu.2018.02501. View

2.
Lo Re 3rd V, Brennan P, Wadlin J, Weaver R, Nachamkin I . Infected branchial cleft cyst due to Bordetella bronchiseptica in an immunocompetent patient. J Clin Microbiol. 2001; 39(11):4210-2. PMC: 88521. DOI: 10.1128/JCM.39.11.4210-4212.2001. View

3.
Yih W, Silva E, Ida J, Harrington N, Lett S, George H . Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis. 1999; 5(3):441-3. PMC: 2640771. DOI: 10.3201/eid0503.990317. View

4.
Yount K, Jennings-Gee J, Caution K, Fullen A, Corps K, Quataert S . Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant. Infect Immun. 2019; 87(10). PMC: 6759310. DOI: 10.1128/IAI.00506-19. View

5.
Gore T, Headley M, Laris R, Bergman J, Sutton D, Horspool L . Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours. Vet Rec. 2005; 156(15):482-3. DOI: 10.1136/vr.156.15.482. View